To investigate the pivotal biological effects of M2-EVs on RCC, M2 TAMs were firstly extracted (Fig. S1A) and presented with positive expressions of markers CD68, CD163 and CD206 in immunofluorescence staining (Fig. S1B). This evidence concerns the gene CD163 and renal cell carcinoma.